Urology Device Market

Urology Device Market Outlook (2024 to 2034)

The global urology device market has been approximated at a value of US$ 13.07 billion in 2024 and is projected to increase at a CAGR of 6.2% to reach US$ 23.8 billion by the end of 2034.

Urology is the branch of medicine that deals with diseases associated with the male and female urinary tract and reproductive system. These diseases include bladder control problems, kidney stones, urinary tract infections, prostate problems, cancer, and others. Urology devices are utilized in the diagnosis and surgical treatment of these diseases, and hence, the field is also known as genitourinary surgery. Some of the common urology diagnostic devices are cystoscopy, ureteroscopy, urodynamic testing, dialysis devices, endoscopes, laser & lithotripsy devices, and endovision systems.

Global statistics of the rising geriatric population are alarming, which, in turn, is expected to increase the cases of age-associated chronic diseases. Urologic diseases arise from the urinary system itself, or they could be secondary to an illness or due to any underlying disease. There has been a dramatic rise in secondary urologic disease cases associated with chronic disorders such as diabetes. As such, demand for urology devices is estimated to increase at a high pace over the coming years.

Rising trend of robotics and automation in urology devices will attract public and private funding for R&D. FDA approvals of recent robotic surgical treatments are encouraging the utilization of urology devices. The Food and Drug Administration (FDA) recently approved the robotic surgical system of Intuitive. Such approvals are encouraging several other robotic innovations in the pipeline.

• North America is projected to account for 33.9% of the global urology device market share by 2034.
• The Western European urology device market size is evaluated at US$ 2.77 billion in 2024.

Report Attribute	Detail
Urology Device Market Size (2024E)	US$ 13.07 Billion
Forecasted Market Value (2034F)	US$ 23.8 Billion
Global Market Growth Rate (2024 to 2034)	6.2% CAGR
South Korea Market Value (2034F)	US$ 1.07 Billion
Dialysis Device Demand Growth Rate (2024 to 2034)	6.6% CAGR
Key Companies Profiled	Siemens AG; Baxter International Inc.; Medtronic; Abbott; Boston Scientific Corporation; Stryker Corporation; Olympus Corporation; Johnson & Johnson Services Inc.; Fresenius Medical Care AG & Co. KGaA; Cook Medical Inc.; Cardinal Health; Intuitive Surgical; KARL STORZ GmbH & Co. KG; Richard Wolf GmbH; Dornier MedTech.

How are Technological Advancements Driving Up Sales of Urology Devices?

“Developments in Treatment Options Increasing Chances of Quick Recovery”

Although the treatment of prostate cancer depends on the diagnosed stage, a particular diagnosis has multiple options for treatment. Urolithiasis or kidney stones are treated with kidney stone management devices such as endoscopy, cystoscopy, and lasers & lithotripsy devices. The urodynamic system is mostly utilized for the treatment of bladder leakage problems.

In the case of prostate cancer, surgical removal, brachytherapy, and radiation therapy are the most utilized treatments. Treatment selection is witnessing evolution with the development of innovations in robotic-assisted prostatectomy and proton beam radiation therapy. Manufacturers of medical devices are collaborating with research institutions to develop advanced urology devices due to the rising prevalence of end-stage renal diseases, chronic kidney diseases, and urethral malignancies.

• In February 2023 Ethicon, a subsidiary of Johnson & Johnson MedTech Company, announced the launch of the MONARCH™ Platform for Urology, the first patient-receiving robotic-assisted device for removal of kidney stones.

Thus, introduction of technologically advanced devices is one of the notable urology device market trends set to boost the profits of suppliers. Such promising advancements are increasing the adoption of cutting-edge urology devices.

“Minimally Invasive Treatment Preferred and Effective Option for Urology-related Disorders”

With the rapidly transforming medical sector, there is a growing preference for minimally invasive surgical treatments that involve one or more small incisions, quicker recovery times, and less discomfort as opposed to conventional surgeries. Innovations in minimally invasive treatment designs to treat prostate cancer are leading to efficient results.

One such example is High-Intensity Focused Ultrasound (HIFU), in which high-intensity ultrasound waves are used to destroy cancer cells while protecting the surrounding healthy tissues. This treatment has better visibility and control during surgery and significantly reduces recovery time. Another example is of Urolift system for the treatment of benign prostate hyperplasia (BPH). This is also a minimally invasive treatment without a catheter, which allows patients to return home the same day.

What Challenges are Brought Up by Technological Advancements?

“High Cost of Advanced Urology Devices and Adverse Effects Associated with Cystoscopies”

Although innovative treatments seem promising, their newness poses a dearth of knowledge in terms of long-term success, reliability, and possible side effects. This has been creating significant hurdles in the quick adoption of advanced urology devices by medical practitioners and patients. High cost of medical devices and stringent regulatory requirements for device approvals are emerging as potential challenges to urology device market growth. Improper use of cystoscopies is leading to issues such as infections, urinary incontinence, bleeding, and bladder perforation, which is further expected to reduce their use.

• According to an article published by Mayo Clinic on cystoscopy, some patients after cystoscopy can witness the inability to urinate, bright red and heavy blood clots in urine, high fever, and abdominal pain.
• As per an article by Nature, office cystoscopy associated with urinary tract infection (UTI) can be 10% to 20%.

Start-up Ecosystem

• RenalTracker is a Netherlands-based start-up that offers a software application that helps users slow down or halt the progression of chronic kidney disease.
• Kite Medical, an Irish start-up, offers a non-invasive, cost-effective, and trauma-free system for the detection of kidney reflux in children through the use of electrical impedance tomography.

Country-wise Analysis

Why are United States-based Urology Device Manufacturers Experiencing High Growth in Their Profits?

“Kidney Disorders One of the Fast-Growing Noncommunicable Diseases among Americans”

Attribute	United States
Market Value (2024E)	US$ 4.06 Billion
Growth Rate (2024 to 2034)	6.9% CAGR
Projected Value (2034F)	US$ 7.96 Billion

Kidney disease is increasing at an alarming rate in the United States. Increasing number of hospitalizations for the diagnosis and treatment of end-stage renal disease (ESRD) and acute kidney injury (AKI) are driving up the adoption of advanced urology technologies in the country.

• According to the American Society of Cancer (ASC), after lung cancer, prostate cancer is the most common cause of cancer death among American men.
• According to an article by American Kidney Fund 2024, around 35.5 million Americans are living with kidney disorders.
• According to the same source, more than 557,000 Americans are on dialysis, and 9 out of 10 are unaware of their kidney-related disorders.

The urologic disease diagnosis and treatment scenario in the United States is complemented by the presence of leading manufacturers of urology devices, including Boston Scientific, Baxter, CR Bard, and Intuitive Surgical. Thus, the country is expected to observe rising demand and supply of urology devices over the coming years.

How is Rising Prevalence of Diabetes Increasing Need for Innovative Urology Devices in India?

“Type 2 Diabetic Patients Have Double Chances of Suffering from Kidney Stones”

Attribute	India
Market Value (2024E)	US$ 637.8 Million
Growth Rate (2024 to 2034)	9.4% CAGR
Projected Value (2034F)	US$ 1.55 Billion

Development of kidney stones is attributed to dietary and lifestyle changes, drinking less water, and some environmental factors. Asia has divergent climates and cultures that make the characteristic prevalent and lead to the surge in the cases of kidney stones.

Further, development of renal stones has been observed to be associated with systemic diseases such as type 2 diabetes mellitus, obesity, dyslipidemia, and hypertension. Southeast Asian countries, notably India, are facing the diabetes epidemic, especially type 2 diabetes, which, in turn, is adding to the incidence of renal stone diagnosis.

• According to the National Center of Biotechnology Information, after China, India holds a leading position in the global diabetes epidemic.

Category-wise Analysis

Which Disease Type is Supporting Sales Growth of Urology Devices?

“Rising Cases of Kidney Diseases Worldwide Pushing Adoption of Advanced Urology Devices”

Attribute	Kidney Diseases
Segment Value (2024E)	US$ 7.42 Billion
Growth Rate (2024 to 2034)	6.2% CAGR
Projected Value (2034F)	US$ 13.52 Billion

• According to a report by Nature 2024, around 850 million people worldwide are living with kidney disease.

Demand for advanced urology devices is being driven by the rising prevalence of kidney diseases across the world. Patients living with kidney disorders primarily prefer dialysis and minimally invasive surgeries.

The geriatric population, who are prone to chronic illnesses such as high blood pressure and diabetes, are more susceptible to kidney diseases. BP and diabetes are key reasons leading to kidney disorders among the aging population. Thus, rising prevalence of kidney disorders is driving the adoption of innovative urology technologies.

Why Do Patients Prefer Hospitals and Clinics for Diagnosis and Treatment?

“Hospitals and Clinics Provide Advanced Treatment and Patient-Centric Care”

Attribute	Hospitals and Clinics
Segment Value (2024E)	US$ 6.87 Billion
Growth Rate (2024 to 2034)	5.9% CAGR
Projected Value (2034F)	US$ 12.25 Billion

• Hospitals and clinics are set to capture 51.5% of the global market share by 2034.

Most target patients prefer taking treatment from hospitals and specialty clinics due to the presence of advanced healthcare systems and technologies. These healthcare facilities offer advanced services for the diagnosis and treatment of urological disorders. Rising popularity of minimally invasive procedures is further positioning hospitals and clinics to be prime treatment providing infrastructures.

Competitive Landscape

Key players in the global urology device market are coming up with innovative marketing ideas to boost their product sales. Majority of the companies are targeting specific consumers with high demand to lead the market by having early entry in segments. They are continuously focusing on advancing their products and are also collaborating with research institutions to introduce technologically advanced devices.

• In March 2024, Intuitive received FDA clearance for the Fifth-Generation Robotic System 'da Vinci 5'.
• In January 2022, Ascend Wellness Holdings, a dialysis testing laboratory, signed a strategic partnership with Siemens Healthineers to expand the testing capacity at Ascend’s new laboratory in California
• In November 2021, a Taiwan-based company, Brain Navi Biotechnology, received CE (Conformité Européenne) mark for its robotic-assisted surgical robot NaoTrac.

Fact.MR provides detailed information about the price points of key manufacturers of urology devices positioned across the world, sales growth, production capacity, and speculative technological expansion, in the recently updated market report.

Key Segments of Urology Device Market Research

• By Product Type :

  • Dialysis Devices
  • Endoscopes
  • Lasers & Lithotripsy Devices
  • Robotic Systems
  • Endovision Systems
  • Peripheral Instruments
  • Urodynamic Systems

• By Disease :

  • Kidney Diseases
  • Cancer & BPH
  • Pelvic Organ Prolapse
  • Others

• By End User :

  • Hospitals & Clinics
  • Dialysis Centers
  • Others

• By Region :

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa